NSE filing, NSE: CYIENT. Summary written from the filing by ALFA Finder's alert engine.
Cyient Ltd: key numbers
- Share price
- ₹1,159.00
- Market cap
- ₹12,879 Cr
- Revenue (annual)
- ₹7,268 Cr
- Net profit (annual)
- ₹427.9 Cr
- P/E (TTM)
- 34.6×Sector 23.0×
- Promoter holding
- 24.76%+1.48% QoQ
- FII holding
- 14.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cyient Ltd
All →Cyient Business Update
Cyient Semiconductors will exhibit at electronica 2026 in Munich, showcasing power management ICs and custom ASIC solutions. No new order or financial figure disclosed.
Cyient Earnings Call Transcript: Key Takeaways
Cyient delivered solid sequential growth led by robust performance in DET and DLM segments, bolstered by the integration of Thau Digital.
Cyient Acquisition Worth ₹0.01 Cr
Cyient Ltd will acquire the remaining 49% stake in subsidiary CSSPL for ₹0.01 Crore, making it a wholly-owned subsidiary.
- Value
- ₹0.01 Cr
- Execution
- 120 days
Cyient Results Update
Cyient reported its Q2 FY27 financial performance showing revenue and EBIT growth. The board also declared an interim dividend of ₹12 per share.
Cyient Dividend
Cyient Limited declared an interim dividend of Rs. 12 per equity share for FY 2026-27. The company fixed October 28, 2026, as the record date.
Cyient Investor Presentation: Key Takeaways
Cyient reported strong Q2 FY27 results with Group revenue reaching ₹2,235 Cr (+25.5% YoY). Strategy focuses on 'Intelligent Lifecycle Engineering' across Aerospace, Semiconductors, and AI.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date